IMBiologics Revenue

Pharmaceutical Manufacturing • Korea, Republic of • 1-10 Employees

IMBiologics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$547,552
Total funding	$15,600,000

Key Contact at IMBiologics

Gyongsik Sik

Chief Executive Officer

Company overview

Headquarters	Korea, Republic of
Phone number	+822019916
Websites	imbiologics.com bios.co.kr
NAICS	3254
Founded	2020
Employees	1-10
Socials

IMBiologics Email Formats

IMBiologics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@imbiologics.com), used 57.1% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@imbiologics.com	57.1%
{first initial}{second initial}.{last name}	jo.doe@imbiologics.com	28.6%
{first initial}.{last name}	j.doe@imbiologics.com	14.3%

About IMBiologics

IMBiologics (IMB) focuses on developing novel treatment options for Immunology & inflammation (I&I) diseases and cancer, utilizing innovative mechanisms of action and/or multivalent antibody platform technology, ePENDY. Given IMB’s successful out-licensing experience of our lead asset, IMB-101, a bispecific antibody targeting OX40L and TNFα in 2024, IMB focuses on two areas: Immuno-oncology and auto-immunity & inflammation with new modalities, including bi-specific antibody and ePENDY.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

IMBiologics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore IMBiologics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-08-24	5	$15,600,000

Funding Insights

$15,600,000

Total funding amount

$15,600,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

IMBiologics is located in KR.

You can reach IMBiologics at +822019916.

IMBiologics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

IMBiologics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

IMBiologics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

IMBiologics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

IMBiologics has raised a total of $15,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at IMBiologics

Gyongsik Sik

Chief Executive Officer

4.8

40,000 users